BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1619518)

  • 21. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
    Denekamp J; Morris C; Field SB
    Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor line dependent interactions of irradiation and cis-diamminedichloroplatinum in the multicellular tumor spheroid system.
    Yuhas JM; Tarleton AE; Culo F
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1373-5. PubMed ID: 575123
    [No Abstract]   [Full Text] [Related]  

  • 23. DNA damage induced in T50/80 tumour cells following exposure to the bioreductive drug Tirapazamine in combination with a single dose of radiation (12Gy).
    Friery OP; Hejmadi MV; McKeown SR
    Biochem Soc Trans; 1997 Feb; 25(1):135S. PubMed ID: 9057033
    [No Abstract]   [Full Text] [Related]  

  • 24. BUdR radiosensitization in anaplastic astrocytoma.
    Yung WK
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1105-6. PubMed ID: 10613300
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin.
    Overgaard J; Khan AR
    Cancer Treat Rep; 1981; 65(5-6):501-3. PubMed ID: 7195305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of radiotherapy in the treatment of lung cancer].
    Van Houtte P
    Rev Med Brux; 1985 Jun; 6(6):397-403. PubMed ID: 4035139
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
    Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
    J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.
    Ma LW; Berg K; Danielsen HE; Kaalhus O; Iani V; Moan J
    Cancer Lett; 1996 Dec; 109(1-2):129-39. PubMed ID: 9020912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
    Zachariae C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1445-8. PubMed ID: 3759571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.
    Kivivuori SM; Riikonen P; Valanne L; Lönnqvist T; Saarinen-Pihkala UM
    Acta Paediatr; 2011 Jan; 100(1):134-8. PubMed ID: 20712831
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 1: Lung Cancer. Puerto Rico, March 12-16, 1997.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-162; quiz S12-163-S12-173. PubMed ID: 9340788
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?
    Browman GP
    Cancer Treat Rep; 1984 Mar; 68(3):465-9. PubMed ID: 6200218
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epithelial cancer of the ovary: current perspectives. (2)].
    Díaz-Rubio-García E; Martín Jiménez M
    Rev Clin Esp; 1983 Sep; 170(5):229-36. PubMed ID: 6359295
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cisplatin and derivatives with radiation therapy: for what clinical use?].
    Durdux C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S88-94. PubMed ID: 15679253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The response of a transplantable tumor to fractionated irradiation. II. Fast neutrons.
    Denekamp J; Harris SR; Morris C; Field SB
    Radiat Res; 1976 Oct; 68(1):93-103. PubMed ID: 967976
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined chemoradiation therapy for limited-stage small-cell lung cancer.
    Teng M; Choy H; Ettinger D
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):107-15. PubMed ID: 10550834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin II.
    Nelson JS; Sun CH; Berns MW
    Lasers Surg Med; 1986; 6(2):131-6. PubMed ID: 2941630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematoporphyrin diethers--V. Plasma protein binding and photosensitizing efficiency.
    Kongshaug M; Rimington C; Evensen JF; Peng Q; Moan J
    Int J Biochem; 1990; 22(10):1127-31. PubMed ID: 2149708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.